Retrieve available abstracts of 207 articles: HTML format
Single Articles
April 2025
EDOARDO G, Arduini A, Iacoviello M, Carugo S, et al Albuminuria Range as a Key Metric Linking Renal Function to Heart Failure Outcome
in FINEARTS-HF.
J Am Coll Cardiol. 2025 Apr 14:S0735-1097(25)05906. PubMed
CLAUDEL SE, Schmidt IM, Waikar SS, Verma A, et al Albuminuria: A Marker of Adverse Kidney Outcomes in Heart Failure.
J Am Coll Cardiol. 2025;85:1372-1375. PubMed
March 2025
PACKER M, Zile MR, Kramer CM, Murakami M, et al Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients
With Heart Failure, Preserved Ejection Fraction, and Obesity: The SUMMIT Trial.
J Am Coll Cardiol. 2025 Mar 24:S0735-1097(25)05340. PubMedAbstract available
MORICI N, Sacco A, Frea S, Rota M, et al Early Intra-Aortic Balloon Support for Heart Failure-Related Cardiogenic Shock: A
Randomized Clinical Trial.
J Am Coll Cardiol. 2025 Mar 21:S0735-1097(25)05334. PubMedAbstract available
PITT B, Budden J, Anker SD, Butler J, et al Reply: The Impact of Patiromer on Heart Failure Treatment With Angiotensin
Inhibitors and MRAs.
J Am Coll Cardiol. 2025;85:e115. PubMed
TANG WZ, Cai QY, Pan YR, Liu TH, et al The Impact of Patiromer on Heart Failure Treatment With Angiotensin Inhibitors
and MRAs.
J Am Coll Cardiol. 2025;85:e113. PubMed
PACKER M Do Potassium Binders Block Both the Benefits and the Risks of Mineralocorticoid
Receptor Antagonists in Heart Failure?: The Four Anti-Aldosterone Myths.
J Am Coll Cardiol. 2025;85:985-987. PubMed
MAURER MS, Witteles RM, Garcia-Pavia P, Sheikh FH, et al Impact of Heart Failure Severity on Vutrisiran Efficacy in Transthyretin
Amyloidosis with Cardiomyopathy.
J Am Coll Cardiol. 2025 Mar 11:S0735-1097(25)05823. PubMedAbstract available
February 2025
LALA A, Coca S, Feinman J, Hamo CE, et al Standardized Definitions of Changes in Kidney Function in Trials of Heart
Failure: JACC Expert Panel From the HF-ARC.
J Am Coll Cardiol. 2025;85:766-781. PubMedAbstract available
KRUMHOLZ HM Heart Failure: Insights From a JACC Special Focus Issue.
J Am Coll Cardiol. 2025;85:683-684. PubMed
MOGHTADERI A, Magid DJ, Yuan AY, Black B, et al The Association of Hospital-Cardiologist Integration With Patient Outcomes,
Care Quality, and Utilization.
J Am Coll Cardiol. 2025;85:352-361. PubMedAbstract available
January 2025
MASI S, Dalpiaz H, Savarese G Under Pressure: The Prognostic Role of Blood Pressure in Heart Failure With
Preserved Ejection Fraction.
J Am Coll Cardiol. 2025 Jan 22:S0735-1097(24)10659. PubMed
BUTLER J, Usman MS, Harrell FE Jr, Packer M, et al Did Finerenone Improve Health Status in the FINEARTS Trial?: A Critical
Reevaluation of the Analysis of Patient-Reported Outcomes in Heart Failure.
J Am Coll Cardiol. 2025;85:190-195. PubMedAbstract available
DAMMAN K When Kidney Function Declines But Therapy Still Works: The Case for Nonsteroidal
MRA Therapy in Heart Failure.
J Am Coll Cardiol. 2025;85:186-189. PubMed
MATSUMOTO S, Jhund PS, Henderson AD, Bauersachs J, et al Initial Decline in Glomerular Filtration Rate With Finerenone in HFmrEF/HFpEF: A
Prespecified Analysis of FINEARTS-HF.
J Am Coll Cardiol. 2025;85:173-185. PubMedAbstract available
KAUL S, Hiremath S Unentangling Heart Failure From Kidney Outcomes With Finerenone: Insights From
the FINEARTS-HF Trial.
J Am Coll Cardiol. 2025;85:169-172. PubMed
CHENG RK, Leedy D, Ruberg FL Can Outpatient Worsening Heart Failure Serve as an Endpoint in Clinical Trials of
Transthyretin Amyloidosis?
J Am Coll Cardiol. 2025 Jan 16:S0735-1097(24)10558. PubMed
CLELAND JGF Prostanoids and Heart Failure: Friend or Foe?
J Am Coll Cardiol. 2025;85:71-73. PubMed
RADE JJ, Kronsberg SS, Kickler TS, Vasan RS, et al Association of Systemic Thromboxane Generation With Risk of Developing
Heart Failure.
J Am Coll Cardiol. 2025;85:58-70. PubMedAbstract available
December 2024
LOWE EF, Gerasta D, Balser M, Page RL 2nd, et al Contributors and Solutions to High Out-of-Pocket Costs for Heart Failure
Medications.
J Am Coll Cardiol. 2024 Dec 17:S0735-1097(24)10426. PubMedAbstract available
FONTANA M, Maurer MS, Gillmore JD, Bender S, et al Worsening of Heart Failure in Outpatients With Transthyretin Amyloidosis and
Cardiomyopathy in the APOLLO-B Trial.
J Am Coll Cardiol. 2024 Dec 16:S0735-1097(24)10297. PubMedAbstract available
VEST AR, Sauer AJ Obesity-Related Heart Failure With Preserved Ejection Fraction: Weighing the
Benefit of Finerenone.
J Am Coll Cardiol. 2024 Dec 6:S0735-1097(24)10542. PubMed
BUTT JH, Henderson AD, Jhund PS, Claggett BL, et al Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection
Fraction: Prespecified Analysis of FINEARTS-HF.
J Am Coll Cardiol. 2024 Dec 4:S0735-1097(24)10423. PubMedAbstract available
O'GARA PT Transcatheter Aortic Valve Replacement in Heart Failure, Reduced Ejection
Fraction, and Moderate Aortic Stenosis.
J Am Coll Cardiol. 2024 Dec 3:S0735-1097(24)10429. PubMed
November 2024
COBURN J, Neef PA, Hobson S, Dalzell JR, et al Clinical Signs of Congestion in Younger Patients With Decompensated
Heart Failure.
J Am Coll Cardiol. 2024;84:e323. PubMed
KONDO T, Henderson AD, Docherty KF, Jhund PS, et al Why Have We Not Been Able to Demonstrate Reduced Mortality in Patients With
HFmrEF/HFpEF?
J Am Coll Cardiol. 2024;84:2233-2240. PubMedAbstract available
KOSIBOROD MN, Cherney DZI, Desai AS, Testani JM, et al Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During
Spironolactone Optimization in Patients with Heart Failure.
J Am Coll Cardiol. 2024 Nov 15:S0735-1097(24)10430. PubMedAbstract available
LU H, Kondo T, Claggett BL, Vaduganathan M, et al Systolic Blood Pressure and Pulse Pressure in Heart Failure:
Pooled Participant-Level Analysis of 4 Trials.
J Am Coll Cardiol. 2024 Nov 15:S0735-1097(24)10420. PubMedAbstract available
FONTANA M, Maurer MS, Gillmore JD, Bender S, et al Outpatient Worsening Heart Failure in Patients with Transthyretin Amyloidosis
with Cardiomyopathy in the HELIOS-B Trial.
J Am Coll Cardiol. 2024 Nov 9:S0735-1097(24)10464. PubMedAbstract available
KRAMER CM, Borlaug BA, Zile M MR, Ruff D, et al Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related
Heart Failure: SUMMIT CMR Substudy.
J Am Coll Cardiol. 2024 Nov 5:S0735-1097(24)10414. PubMedAbstract available
October 2024
NEUEN BL, Badve SV, Arnott C Optimizing Clinical Outcomes Beyond Heart Failure With Intravenous Iron.
J Am Coll Cardiol. 2024;84:1718-1720. PubMed
CLELAND JGF, Pellicori P, Graham FJ, Lane R, et al Adjudication of Hospitalizations and Deaths in the IRONMAN Trial of Intravenous
Iron for Heart Failure.
J Am Coll Cardiol. 2024;84:1704-1717. PubMedAbstract available
DRONKERS J, van Veldhuisen DJ, van der Meer P, Meems LMG, et al Heart Failure and Obesity: Unraveling Molecular Mechanisms of Excess Adipose
Tissue.
J Am Coll Cardiol. 2024;84:1666-1677. PubMedAbstract available
VAN MIEGHEM NM, Elmariah S, Spitzer E, Pibarot P, et al Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure
and Moderate Aortic Stenosis: TAVR UNLOAD.
J Am Coll Cardiol. 2024 Oct 22:S0735-1097(24)09960. PubMedAbstract available
MC CAUSLAND FR, Vaduganathan M, Claggett BL, Kulac IJ, et al Finerenone and Kidney Outcomes in Patients with Heart Failure: The FINEARTS-HF
Trial.
J Am Coll Cardiol. 2024 Oct 22:S0735-1097(24)10252. PubMedAbstract available
GENEREUX P, Gupta A, Makkar RR TAVR in Patients with Moderate Aortic Stenosis and Heart Failure.
J Am Coll Cardiol. 2024 Oct 21:S0735-1097(24)10056. PubMed
LANDSTEINER I, Ramesh A, Yang BQ, Lewis GD, et al Hemodynamic Insights From Provocative Testing in Pulmonary Hypertension and
Heart Failure With Preserved Ejection Fraction.
J Am Coll Cardiol. 2024 Oct 16:S0735-1097(24)09806. PubMed
AIMO A, Panichella G, Vergaro G, Bayes-Genis A, et al Bridging Atrial and Ventricular Failure Through Biomarkers.
J Am Coll Cardiol. 2024;84:1541-1544. PubMed
TALHA KM, Butler J, Packer M Consequences of Discontinuing Long-Term Drug Treatment in Patients With
Heart Failure and Reduced Ejection Fraction.
J Am Coll Cardiol. 2024 Oct 15:S0735-1097(24)08453. PubMedAbstract available
REDDY YNV, Frantz RP, Hassoun PM, Hemnes AR, et al Clinical Implications of Pretest Probability of HFpEF on Outcomes in
Precapillary Pulmonary Hypertension.
J Am Coll Cardiol. 2024 Oct 15:S0735-1097(24)08392. PubMedAbstract available
ROSMAN L, Lampert R, Wang K, Gehi AK, et al Machine Learning-Based Prediction of Death and Hospitalization in Patients With
Implantable Cardioverter Defibrillators.
J Am Coll Cardiol. 2024 Oct 15:S0735-1097(24)08455. PubMedAbstract available
VARGA CR, Cleland JGF, Abraham WT, Lip GYH, et al Implantable Cardioverter Defibrillator and Resynchronization Therapy in Patients
With Overt Chronic Kidney Disease: JACC State-of-the-Art Review.
J Am Coll Cardiol. 2024;84:1342-1362. PubMedAbstract available
GREENE SJ, Spahillari A, Shahzeb Khan M Enabling Medical Therapy for Heart Failure: New Tools Bring a New Reality for
Hyperkalemia.
J Am Coll Cardiol. 2024;84:1309-1312. PubMed
PITT B, Anker SD, Lund LH, Coats AJS, et al Patiromer Facilitates Angiotensin Inhibitor and Mineralocorticoid Antagonist
Therapies in Patients With Heart Failure and Hyperkalemia.
J Am Coll Cardiol. 2024;84:1295-1308. PubMedAbstract available
September 2024
LINDBERG F, Savarese G Worsening Heart Failure: An Opportunity for Treatment Implementation Even With
a Preserved Ejection Fraction?
J Am Coll Cardiol. 2024 Sep 29:S0735-1097(24)08531. PubMed
YANG M, Henderson AD, Talebi A, Atherton JJ, et al Effect of Finerenone on the KCCQ in Patients With HFmrEF/HFpEF:
A Prespecified Analysis of FINEARTS-HF.
J Am Coll Cardiol. 2024 Sep 29:S0735-1097(24)08532. PubMedAbstract available
VADUGANATHAN M, Claggett BL, Desai AS, Jhund PS, et al Time to Significant Benefit of Finerenone in Patients With Heart Failure.
J Am Coll Cardiol. 2024 Sep 26:S0735-1097(24)08512. PubMed
DESAI AS, Vaduganathan M, Claggett BL, Kulac IJ, et al Finerenone in Patients With a Recent Worsening Heart Failure Event: The
FINEARTS-HF Trial.
J Am Coll Cardiol. 2024 Sep 25:S0735-1097(24)08452. PubMedAbstract available
MATSUMOTO S, Shen L, Henderson AD, Bohm M, et al Asymptomatic vs Symptomatic Hypotension With Sacubitril/Valsartan in
Heart Failure and Reduced Ejection Fraction in PARADIGM-HF.
J Am Coll Cardiol. 2024 Sep 21:S0735-1097(24)08162. PubMedAbstract available
MENTZ RJ, Kittipibul V Improving Health Status With SGLT2 Inhibitors Following Worsening Heart Failure:
Fighting an Uphill Battle.
J Am Coll Cardiol. 2024;84:1089-1091. PubMed
BHATT AS, Bhatt DL, Steg PG, Szarek M, et al Effects of Sotagliflozin on Health Status in Patients With Worsening
Heart Failure: Results From SOLOIST-WHF.
J Am Coll Cardiol. 2024;84:1078-1088. PubMedAbstract available
NEVES JS, Zannad F, Butler J, Packer M, et al Should the SELECT Trial Make Us Comfortable Using GLP-1 Receptor Agonists in
HFrEF?
J Am Coll Cardiol. 2024;84:1119-1122. PubMed
MURAKAMI T Significance of B-Type Natriuretic Peptide Level in Patients With Small Left
Ventricle.
J Am Coll Cardiol. 2024;84:e87. PubMed
August 2024
PONIKOWSKI P, Friede T, von Bardeleben RS, Butler J, et al Hospitalization of Symptomatic Patients With Heart Failure and Moderate to Severe
Functional Mitral Regurgitation Treated With MitraClip: Insights From
RESHAPE-HF2.
J Am Coll Cardiol. 2024 Aug 30:S0735-1097(24)08233. PubMedAbstract available
ANKER MS, Porthun J, Schulze PC, Rassaf T, et al Percutaneous Transcatheter Edge-To-Edge Repair for Functional Mitral
Regurgitation in Heart Failure: A Meta-Analysis of 3 Randomized Controlled
Trials.
J Am Coll Cardiol. 2024 Aug 29:S0735-1097(24)08231. PubMed
SOLOMON SD, Ostrominski JW, Wang X, Shah SJ, et al Effect of Semaglutide on Cardiac Structure and Function in Patients With
Obesity-Related Heart Failure.
J Am Coll Cardiol. 2024 Aug 29:S0735-1097(24)08192. PubMedAbstract available
VERMA S, Butler J, Borlaug BA, Davies MJ, et al Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure With
Preserved Ejection Fraction: STEP-HFpEF Program.
J Am Coll Cardiol. 2024 Aug 29:S0735-1097(24)08195. PubMedAbstract available
MODIN D, Claggett B, Johansen ND, Solomon SD, et al Excess mortality and hospitalizations associated with seasonal influenza in
patients with heart failure.
J Am Coll Cardiol. 2024 Aug 28:S0735-1097(24)08311. PubMedAbstract available
VERMA S, Petrie MC, Borlaug BA, Butler J, et al Inflammation in Obesity-Related HFpEF: The STEP-HFpEF Program.
J Am Coll Cardiol. 2024 Aug 28:S0735-1097(24)08234. PubMedAbstract available
MEWTON N, Zores F, Packer M Catheter Ablation for Atrial Fibrillation in Advanced Heart Failure: Can We Trust
the CASTLE-HTx Trial?
J Am Coll Cardiol. 2024;84:862-864. PubMed
HAHN RT, Lindenfeld J, Lim SD, Mack MJ, et al Structural Cardiac Interventions in Patients With Heart Failure: JACC Scientific
Statement.
J Am Coll Cardiol. 2024;84:832-847. PubMedAbstract available
OSTROMINSKI JW, Lala A Incretin-Based Therapies in Women With Obesity-Related HFpEF: Time to STEP Into a
Paradigm of Integrated Care.
J Am Coll Cardiol. 2024;84:786-789. PubMed
VADUGANATHAN M, Neuen BL, McCausland F, Jhund PS, et al Why Has it Been Challenging to Modify Kidney Disease Progression in Patients With
Heart Failure?
J Am Coll Cardiol. 2024 Aug 27:S0735-1097(24)08242. PubMed
KITTIPIBUL V, Mentz RJ Effects of GLP-1 Receptor Agonists on Heart Failure Outcomes: The FLOW of
Evidence.
J Am Coll Cardiol. 2024 Aug 24:S0735-1097(24)08168. PubMed
PRATLEY RE, Tuttle KR, Rossing P, Rasmussen S, et al Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney
Disease in the FLOW Trial.
J Am Coll Cardiol. 2024 Aug 23:S0735-1097(24)08116. PubMedAbstract available
PACKER M, Ferreira JP, Butler J, Filippatos G, et al Reaffirmation of Mechanistic Proteomic Signatures Accompanying SGLT2 Inhibition
in Patients With Heart Failure: A Validation Cohort of the EMPEROR Program.
J Am Coll Cardiol. 2024 Aug 20:S0735-1097(24)07897. PubMedAbstract available
HALLER PM, Jarolim P, Palazzolo MG, Bellavia A, et al Heart Failure Risk Assessment Using Biomarkers in Patients With
Atrial Fibrillation: Analysis From COMBINE-AF.
J Am Coll Cardiol. 2024 Aug 19:S0735-1097(24)07965. PubMedAbstract available
PATEL RB Mechanistic Insights of SGLT2 Inhibition in Heart Failure Through Proteomics:
Appreciating the Cardiovascular-Kidney Connection.
J Am Coll Cardiol. 2024 Aug 12:S0735-1097(24)08016. PubMed
OSTROMINSKI JW, Jemma Cho SM, Vaduganathan M, Honigberg MC, et al Cardiorenal Outcomes in Middle-Aged and Older Adults With Type 1 and Type 2
Diabetes.
J Am Coll Cardiol. 2024 Aug 7:S0735-1097(24)07747. PubMed
KITTLESON MM, Breathett K, Ziaeian B, Aguilar D, et al 2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for
Adults With Heart Failure: A Report of the American Heart Association/American
College of Cardiology Joint Committee on Performance Measures.
J Am Coll Cardiol. 2024 Aug 5:S0735-1097(24)07288. PubMedAbstract available
HOLLENBERG SM, Stevenson LW, Ahmad T, Bozkurt B, et al 2024 ACC Expert Consensus Decision Pathway on Clinical Assessment, Management,
and Trajectory of Patients Hospitalized With Heart Failure Focused Update: A
Report of the American College of Cardiology Solution Set Oversight Committee.
J Am Coll Cardiol. 2024 Aug 2:S0735-1097(24)07449. PubMed
July 2024
BIEGUS J, Mebazaa A, Davison B, Cotter G, et al Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable
Decongestion and Outcomes in STRONG-HF.
J Am Coll Cardiol. 2024;84:323-336. PubMedAbstract available
LOPEZ J, Liu Y, Butler J, Del Prato S, et al Racial Differences in Diabetic Cardiomyopathy: The ARISE-HF Trial.
J Am Coll Cardiol. 2024;84:233-243. PubMedAbstract available
HAHN RT, Lindenfeld J, Bohm M, Edelmann F, et al Tricuspid Regurgitation in Patients With Heart Failure and Preserved
Ejection Fraction: JACC State-of-the-Art Review.
J Am Coll Cardiol. 2024;84:195-212. PubMedAbstract available
PETRIE MC, Borlaug BA, Butler J, Davies MJ, et al Semaglutide and NT-proBNP in Obesity-Related HFpEF:
Insights From the STEP-HFpEF Program.
J Am Coll Cardiol. 2024;84:27-40. PubMedAbstract available
VAN KIMMENADE RRJ, Hassing C STEP-HFpEF: A Large Step for HFpEF.
J Am Coll Cardiol. 2024;84:41-42. PubMed
June 2024
CHEEMA B, Chokshi A, Orimoloye O, Ardehali H, et al Intravenous Iron Repletion for Patients With Heart Failure and Iron Deficiency:
JACC State-of-the-Art Review.
J Am Coll Cardiol. 2024;83:2674-2689. PubMedAbstract available
VERMA S, Butler J, Borlaug BA, Davies M, et al Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With
Preserved Ejection Fraction: STEP-HFpEF Trials.
J Am Coll Cardiol. 2024 Jun 19:S0735-1097(24)07445. PubMedAbstract available
SCHOU M, Petrie MC, Borlaug BA, Butler J, et al Semaglutide and NYHA Functional Class in Obesity-Related Heart Failure With
Preserved Ejection Fraction: The STEP-HFpEF Program.
J Am Coll Cardiol. 2024 Jun 12:S0735-1097(24)07126. PubMedAbstract available
LALA A, Mentz RJ, Santos-Gallego CG The Quest for Understanding Diabetic Cardiomyopathy: Can We Preserve Function and
Prevent Failure?
J Am Coll Cardiol. 2024 Jun 12:S0735-1097(24)07407. PubMed
MESSORI A, Romeo MR, Trippoli S Remote Monitoring in Heart Failure: Inclusion of Different Studies in the
Same Meta-Analysis.
J Am Coll Cardiol. 2024;83:e231. PubMed
KOCHAR A, Gattani R, Vaduganathan M Patient Selection Is the Key to EMPACTing Development of Heart Failure After
Myocardial Infarction.
J Am Coll Cardiol. 2024;83:2247-2249. PubMed
CANNATA A, Bromage DI, Piper SE, McDonagh TA, et al Heart Failure With Preserved Ejection Fraction: Prioritizing Patients' Symptoms.
J Am Coll Cardiol. 2024 Jun 11:S0735-1097(24)07300. PubMed
May 2024
KONDO T, Mogensen UM, Talebi A, Gasparyan SB, et al Dapagliflozin and Days of Full Health Lost in the DAPA-HF Trial.
J Am Coll Cardiol. 2024;83:1973-1986. PubMedAbstract available
OSTROMINSKI JW, Claggett BL, Miao ZM, Mc Causland FR, et al Cardiovascular-Kidney-Metabolic Overlap in Heart Failure with Mildly Reduced or
Preserved Ejection Fraction: A Trial-Level Analysis.
J Am Coll Cardiol. 2024 May 9:S0735-1097(24)07204. PubMed
FERRO CJ, Townend JN Mineralocorticoid Receptor Antagonism in Heart Failure and
Chronic Kidney Disease: Short-Term Pain for Long-Term Gain.
J Am Coll Cardiol. 2024 May 6:S0735-1097(24)06944. PubMed
MATSUMOTO S, Henderson AD, Shen L, Yang M, et al Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and
Impaired Renal Function.
J Am Coll Cardiol. 2024 May 6:S0735-1097(24)06945. PubMedAbstract available
April 2024
KITTIPIBUL V, Cox ZL, Chesdachai S, Fiuzat M, et al Genitourinary Tract Infections in Patients Taking SGLT2 Inhibitors: JACC Review
Topic of the Week.
J Am Coll Cardiol. 2024;83:1568-1578. PubMedAbstract available
BURCHILL LJ, Jain CC, Miranda WR Advancing New Solutions for Adult Congenital Heart Disease-Related Heart Failure.
J Am Coll Cardiol. 2024;83:1415-1417. PubMed
MARTON A, Saffari SE, Rauh M, Sun RN, et al Water Conservation Overrides Osmotic Diuresis During SGLT2 Inhibition in Patients
With Heart Failure.
J Am Coll Cardiol. 2024;83:1386-1398. PubMedAbstract available
NEIJENHUIS RML, MacDonald ST, Zemrak F, Mertens BJA, et al Effect of Sodium-Glucose Cotransporter 2 Inhibitors in Adults With Congenital
Heart Disease.
J Am Coll Cardiol. 2024;83:1403-1414. PubMedAbstract available
ACHANTA A, Belak L, Ritchie CS, Januzzi JL, et al Age-Related Usage of GLP-1 Agonists in Obese Patients With Heart Failure
and Preserved Ejection Fraction.
J Am Coll Cardiol. 2024;83:1348-1350. PubMed
COSTANZO MR, Januzzi JL Early SGLT2 Inhibitors in Acute Heart Failure: Safe Diuretic-Sparing Strategy.
J Am Coll Cardiol. 2024;83:1307-1309. PubMed
COX ZL, Collins SP, Hernandez GA, McRae AT 3rd, et al Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure.
J Am Coll Cardiol. 2024;83:1295-1306. PubMedAbstract available
COTTER G, Davison B, Chioncel O Enhanced Decongestive Therapy in Patients With Acute Heart Failure: JACC Review
Topic of the Week.
J Am Coll Cardiol. 2024;83:1243-1252. PubMedAbstract available
UDELL JA, Petrie MC, Jones WS, Anker SD, et al Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart
Failure Risk After Myocardial Infarction.
J Am Coll Cardiol. 2024 Apr 1:S0735-1097(24)06757. PubMedAbstract available
CHATUR S, Neuen BL, Claggett BL, Beldhuis IE, et al Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in
Patients With Heart Failure.
J Am Coll Cardiol. 2024 Apr 1:S0735-1097(24)06691. PubMedAbstract available
MINHAS AMK, Mathew RO, Sperling LS, Nambi V, et al Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States.
J Am Coll Cardiol. 2024 Apr 1:S0735-1097(24)00940. PubMed
March 2024
ATALLAH B, Ghalib HH Pooling the NT-proBNP Benefits of ARNI: Fret the Index Hospitalization No More.
J Am Coll Cardiol. 2024;83:1133-1135. PubMed
MORROW DA, Velazquez EJ, Desai AS, DeVore AD, et al Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure.
J Am Coll Cardiol. 2024;83:1123-1132. PubMedAbstract available
GONZALEZ-LOPEZ E, McPhail ED, Salas-Anton C, Dominguez F, et al Histological Typing in Patients With Cardiac Amyloidosis: JACC Review Topic of
the Week.
J Am Coll Cardiol. 2024;83:1085-1099. PubMedAbstract available
FOA A, Vaduganathan M, Claggett BL, Pabon MA, et al Sacubitril/Valsartan-Related Hypotension in Patients with Heart Failure and
Preserved or Mildly Reduced Ejection Fraction.
J Am Coll Cardiol. 2024 Mar 13:S0735-1097(24)00478. PubMedAbstract available
FUSTER V Editor-in-Chief's Top Picks From 2023.
J Am Coll Cardiol. 2024;83:961-1026. PubMedAbstract available
HAGE C, Sundstrom J, Lund LH More evidence that heart failure with normal EF distinct from heart failure is
below normal EF.
J Am Coll Cardiol. 2024 Mar 12:S0735-1097(24)00990. PubMed
NEWMAN JD, O'Meara E, Bohm M, Savarese G, et al Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients
With Heart Failure: JACC State-of-the-Art Review.
J Am Coll Cardiol. 2024;83:932-950. PubMedAbstract available
UDELL JA, Armstrong DWJ Targeting the Natriuretic Peptide System to Improve Outcomes: PARADISE Lost or
Found.
J Am Coll Cardiol. 2024;83:915-917. PubMed
MANN DL, Nicolas J, Claggett B, Miao ZM, et al Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI.
J Am Coll Cardiol. 2024;83:904-914. PubMedAbstract available
MADDOX TM, Januzzi JL Jr, Allen LA, Breathett K, et al 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With
Reduced Ejection Fraction: A Report of the American College of Cardiology
Solution Set Oversight Committee.
J Am Coll Cardiol. 2024 Mar 2:S0735-1097(23)08354. PubMed
February 2024
BOTTINOR W, Im C, Doody DR, Armenian SH, et al Mortality After Major Cardiovascular Events in Survivors of Childhood Cancer.
J Am Coll Cardiol. 2024;83:827-838. PubMedAbstract available
BARIANI R, Rigato I, Celeghin R, Marinas MB, et al Phenotypic Expression and Clinical Outcomes in Patients With Arrhythmogenic
Cardiomyopathies.
J Am Coll Cardiol. 2024;83:797-807. PubMedAbstract available
YOO JE, Kim M, Kim B, Lee H, et al Increased Risk of Myocardial Infarction, Heart Failure, and Atrial Fibrillation
After Spinal Cord Injury.
J Am Coll Cardiol. 2024;83:741-751. PubMedAbstract available
FUDIM M, Butler J, Kittipibul V Implantable Hemodynamic-GUIDE Monitors: A CHAMPION Among Devices for
Heart Failure.
J Am Coll Cardiol. 2024;83:695-698. PubMed
LINDENFELD J, Costanzo MR, Zile MR, Ducharme A, et al Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure
and Reduced Ejection Fraction.
J Am Coll Cardiol. 2024;83:682-694. PubMedAbstract available
SCHUMACHER KR, Vitale C It Is Shocking How Little We Have Talked About Cardiogenic Shock in Pediatrics.
J Am Coll Cardiol. 2024;83:609-610. PubMed
PURI K, Jentzer JC, Spinner JA, Hope KD, et al Clinical Presentation, Classification, and Outcomes of Cardiogenic Shock in
Children.
J Am Coll Cardiol. 2024;83:595-608. PubMedAbstract available
January 2024
CHHATRIWALLA AK, Cohen DJ, Vemulapalli S, Vekstein A, et al Transcatheter Edge-to-Edge Repair in COAPT-Ineligible Patients With
Functional Mitral Regurgitation.
J Am Coll Cardiol. 2024;83:488-499. PubMedAbstract available
TROLLE LAGERROS Y, Grotta A, Freyland S, Grannas D, et al Risk of Death in Patients With Coronary Artery Disease Taking Nitrates and
Phosphodiesterase-5 Inhibitors.
J Am Coll Cardiol. 2024;83:417-426. PubMedAbstract available
PACKER M Hyperuricemia and Gout Reduction by SGLT2 Inhibitors in Diabetes and
Heart Failure: JACC Review Topic of the Week.
J Am Coll Cardiol. 2024;83:371-381. PubMedAbstract available
ALOGNA A, Berboth L, Faragli A, Otvos J, et al Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of
Chronic Heart Failure.
J Am Coll Cardiol. 2024;83:47-59. PubMedAbstract available
December 2023
LAMBERT G, Chemello K, Gallo A Lipoprotein(a): More Than Just a Biomarker of Myocardial Fibrosis.
J Am Coll Cardiol. 2023;82:2292-2295. PubMed
November 2023
VADUGANATHAN M, Ostrominski JW Glucagon-Like Peptide-1 Receptor Agonists in Heart Failure: STEPping Across the
Ejection Fraction Divide.
J Am Coll Cardiol. 2023;82:2097-2100. PubMed
BUTLER J, Abildstrom SZ, Borlaug BA, Davies MJ, et al Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or
Preserved Ejection Fraction.
J Am Coll Cardiol. 2023;82:2087-2096. PubMedAbstract available
LOWERY MM, Hill NS, Wang L, Rosenzweig EB, et al Sleep-Related Hypoxia, Right Ventricular Dysfunction, and Survival in Patients
With Group 1 Pulmonary Arterial Hypertension.
J Am Coll Cardiol. 2023;82:1989-2005. PubMedAbstract available
BURGER PM, Visseren FLJ, Dorresteijn JAN Reply: C-Reactive Protein and Heart Failure in Patients With Established
Cardiovascular Disease: Evidence From UK Biobank.
J Am Coll Cardiol. 2023;82:e193. PubMed
MORZE J, Rynkiewicz A C-Reactive Protein and Heart Failure in Patients With Established Cardiovascular
Disease: Evidence From UK Biobank.
J Am Coll Cardiol. 2023;82:e191-e192. PubMed
LAU ES, Di Achille P, Kopparapu K, Andrews CT, et al Deep Learning-Enabled Assessment of Left Heart Structure and Function Predicts
Cardiovascular Outcomes.
J Am Coll Cardiol. 2023;82:1936-1948. PubMedAbstract available
OUWERKERK W, Belo Pereira JP, Maasland T, Emmens JE, et al Multiomics Analysis Provides Novel Pathways Related to Progression of
Heart Failure.
J Am Coll Cardiol. 2023;82:1921-1931. PubMedAbstract available
COCA SG SGLT2i and Deterioration of Kidney Function in Heart Failure: Another
Demonstration for Tolerance of "Hypercreatininemia".
J Am Coll Cardiol. 2023;82:1864-1867. PubMed
AGGARWAL R, Bhatt DL, Szarek M, Cannon CP, et al Efficacy of Sotagliflozin in Adults With Type 2 Diabetes in Relation to Baseline
Hemoglobin A1c.
J Am Coll Cardiol. 2023;82:1842-1851. PubMedAbstract available
October 2023
REIL JC, Eitel I, Stiermaier T Reply: Similarities to Pacing-Induced Heart Failure.
J Am Coll Cardiol. 2023;82:e145. PubMed
KOMAMURA K Similarities to Pacing-Induced Heart Failure.
J Am Coll Cardiol. 2023;82:e143. PubMed
HONG KN, Eshraghian EA, Arad M, Argiro A, et al International Consensus on Differential Diagnosis and Management of Patients With
Danon Disease: JACC State-of-the-Art Review.
J Am Coll Cardiol. 2023;82:1628-1647. PubMedAbstract available
ARNOLD SV, Goates S, Sorajja P, Adams DH, et al Health Status after Transcatheter Tricuspid-Valve Repair in Patients with Severe
Tricuspid Regurgitation: Results from the TRILUMINATE Pivotal Trial.
J Am Coll Cardiol. 2023 Oct 16:S0735-1097(23)07743. PubMedAbstract available
OHSHIRO Y Empagliflozin in Patients With Heart Failure: Efficacy and Safety Concerns Across
Kidney Risk Categories.
J Am Coll Cardiol. 2023;82:e133. PubMed
TEDFORD RJ, Leacche M, Lorts A, Drakos SG, et al Durable Mechanical Circulatory Support: JACC Scientific Statement.
J Am Coll Cardiol. 2023;82:1464-1481. PubMedAbstract available
GREGSON J, Stone GW, Bhatt DL, Packer M, et al Recurrent Events in Cardiovascular Trials: JACC State-of-the-Art Review.
J Am Coll Cardiol. 2023;82:1445-1463. PubMedAbstract available
September 2023
VERBRUGGE FH, Martens P, Mullens W Reply: Acetazolamide in Acute Decompensated Heart Failure.
J Am Coll Cardiol. 2023;82:e113. PubMed
PAI RG Acetazolamide in Acute Decompensated Heart Failure.
J Am Coll Cardiol. 2023;82:e111. PubMed
GOEL K, Lindenfeld J, Makkar R, Naik H, et al Transcatheter Edge-to-Edge Repair in 5,000 Patients With Secondary
Mitral Regurgitation: COAPT Post-Approval Study.
J Am Coll Cardiol. 2023;82:1281-1297. PubMedAbstract available
August 2023
NAYAK A, Hall SA, Uriel N, Goldstein DJ, et al Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated
Left Ventricular Assist Device.
J Am Coll Cardiol. 2023;82:771-781. PubMedAbstract available
CHATUR S, Vaduganathan M, Claggett BL, Mc Causland FR, et al Dapagliflozin in Patients with Heart Failure and Deterioration in Estimated
Glomerular Filtration Rate to <25ml/min/1.73m(2).
J Am Coll Cardiol. 2023 Aug 23:S0735-1097(23)06532. PubMedAbstract available
CHRISPIN J, Merchant FM, Lakdawala NK, Wu KC, et al Risk of Arrhythmic Death in Patients With Nonischemic Cardiomyopathy: JACC Review
Topic of the Week.
J Am Coll Cardiol. 2023;82:735-747. PubMedAbstract available
GREENE SJ, Bauersachs J, Brugts JJ, Ezekowitz JA, et al Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus
Seminar 3/3.
J Am Coll Cardiol. 2023;82:559-571. PubMedAbstract available
JALLOH MB, Averbuch T, Kulkarni P, Granger CB, et al Bridging Treatment Implementation Gaps in Patients With Heart Failure: JACC Focus
Seminar 2/3.
J Am Coll Cardiol. 2023;82:544-558. PubMedAbstract available
PATOLIA H, Khan MS, Fonarow GC, Butler J, et al Implementing Guideline-Directed Medical Therapy for Heart Failure: JACC Focus
Seminar 1/3.
J Am Coll Cardiol. 2023;82:529-543. PubMedAbstract available
GRAPSA J, Pinney SP Right Heart Dysfunction in HFpEF: More Complex and More Common Than We Thought.
J Am Coll Cardiol. 2023;82:500-502. PubMed
BUTLER J, Khan MS, Fonarow GC The Need for Global Optimization of Heart Failure Therapy: Some Differences Do
Not Matter.
J Am Coll Cardiol. 2023 Aug 2:S0735-1097(23)05963. PubMed
KONDO T, Wang X, Yang M, Jhund PS, et al Efficacy of Dapagliflozin According to Geographic Location of Patients With
Heart Failure.
J Am Coll Cardiol. 2023 Aug 2:S0735-1097(23)05964. PubMedAbstract available
SROUBEK J, Vajapey R, Sipko JJ, Soltesz EG, et al First-in-Human Experience With Impella 5.0/5.5 for High-Risk Patients With
Advanced Heart Failure Undergoing VT Ablation.
J Am Coll Cardiol. 2023;82:469-471. PubMed
DEVORE AD, Allen LA A Global Challenge and a Global Opportunity for the Heart Failure Community.
J Am Coll Cardiol. 2023;82:445-447. PubMed
FOROUTAN F, Rayner DG, Ross HJ, Ehler T, et al Global Comparison of Readmission Rates for Patients With Heart Failure.
J Am Coll Cardiol. 2023;82:430-444. PubMedAbstract available
JIALAL I, Ebong IA The Evolving Role of C-Reactive Protein in Heart Failure: Implications for
Patients With Cardiovascular Disease.
J Am Coll Cardiol. 2023;82:427-429. PubMed
BURGER PM, Koudstaal S, Mosterd A, Fiolet ATL, et al C-Reactive Protein and Risk of Incident Heart Failure in Patients
With Cardiovascular Disease.
J Am Coll Cardiol. 2023;82:414-426. PubMedAbstract available
SAUER AJ, Hsia J Initiating Mineralocorticoid Antagonists for Longstanding Heart Failure With
Reduced Ejection Fraction: Better Late Than Never?
J Am Coll Cardiol. 2023 Aug 1:S0735-1097(23)06074. PubMed
MATSUMOTO S, Kondo T, Jhund PS, Campbell RT, et al Underutilization of Mineralocorticoid Antagonists in Patients With Heart Failure
With Reduced Ejection Fraction.
J Am Coll Cardiol. 2023 Aug 1:S0735-1097(23)06073. PubMedAbstract available
July 2023
VIJAYARAMAN P, Sharma PS, Cano O, Ponnusamy SS, et al Comparison of Left Bundle Branch Area Pacing and Biventricular
Pacing in Candidates for Resynchronization Therapy.
J Am Coll Cardiol. 2023;82:228-241. PubMedAbstract available
DOCHERTY KF, McDowell K, Welsh P, Osmanska J, et al Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in
Patients With Heart Failure.
J Am Coll Cardiol. 2023;82:142-157. PubMedAbstract available
ANKER MS, von Haehling S, Landmesser U Understanding Who Responds to M-TEER in Heart Failure With SMR: Malnutrition Does
Not Preclude Benefit.
J Am Coll Cardiol. 2023;82:139-141. PubMed
BAYES-GENIS A, de la Espriella R, Nunez J CA125 for Fluid Overload Monitoring: A New Life for an Old Tool.
J Am Coll Cardiol. 2023;82:158-160. PubMed
GRINSTEIN J, Belkin MN, Kalantari S, Bourque K, et al Adverse Hemodynamic Consequences of Continuous Left Ventricular
Mechanical Support: JACC Review Topic of the Week.
J Am Coll Cardiol. 2023;82:70-81. PubMedAbstract available
June 2023
WIVIOTT SD, Berg DD SGLT2 Inhibitors Reduce Heart Failure Hospitalization and Cardiovascular Death:
Clarity and Consistency.
J Am Coll Cardiol. 2023;81:2388-2390. PubMed
USMAN MS, Siddiqi TJ, Anker SD, Bakris GL, et al Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient
Populations.
J Am Coll Cardiol. 2023;81:2377-2387. PubMedAbstract available
GODOY LC, Farkouh ME, Austin PC, Shah BR, et al Association of Beta-Blocker Therapy With Cardiovascular Outcomes in Patients
With Stable Ischemic Heart Disease.
J Am Coll Cardiol. 2023;81:2299-2311. PubMedAbstract available
STEVENSON LW, Ross HJ, Rathman LD, Boehmer JP, et al Remote Monitoring for Heart Failure Management at Home.
J Am Coll Cardiol. 2023;81:2272-2291. PubMedAbstract available
GOLDBERG LR Disrupting the Definition of Heart Failure: A Rose by Any Other Name.
J Am Coll Cardiol. 2023;81:2243-2245. PubMed
MOHEBI R, Wang D, Lau ES, Parekh JK, et al Effect of 2022 ACC/AHA/HFSA Criteria on Stages of Heart Failure in a Pooled
Community Cohort.
J Am Coll Cardiol. 2023;81:2231-2242. PubMedAbstract available
LEWIS MJ, Reardon LC, Aboulhosn J, Haeffele C, et al Morbidity and Mortality in Adult Fontan Patients After Heart or Combined
Heart-Liver Transplantation.
J Am Coll Cardiol. 2023;81:2161-2171. PubMedAbstract available
FONAROW GC, Greene SJ Rapid and Intensive Guideline-Directed Medical Therapy for Heart Failure: Strong
Impact Across Ejection Fraction Spectrum.
J Am Coll Cardiol. 2023;81:2145-2148. PubMed
PAGNESI M, Metra M, Cohen-Solal A, Edwards C, et al Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of
Left Ventricular Ejection Fraction.
J Am Coll Cardiol. 2023;81:2131-2144. PubMedAbstract available
May 2023
KAZI DS, DeJong C, Chen R, Wadhera RK, et al The Inflation Reduction Act and Out-of-Pocket Drug Costs for
Medicare Beneficiaries With Cardiovascular Disease.
J Am Coll Cardiol. 2023;81:2103-2111. PubMedAbstract available
SCOTTI A, Coisne A, Granada JF, Driggin E, et al Impact of Malnutrition in Patients With Heart Failure and Secondary
Mitral Regurgitation: The COAPT Trial.
J Am Coll Cardiol. 2023 May 27:S0735-1097(23)05584. PubMedAbstract available
SUKUMAR S, Wasfy JH, Januzzi JL, Peppercorn J, et al Financial Toxicity of Medical Management of Heart Failure: JACC Review Topic of
the Week.
J Am Coll Cardiol. 2023;81:2043-2055. PubMedAbstract available
VERBRUGGE FH, Martens P, Dauw J, Nijst P, et al Natriuretic Response to Acetazolamide in Patients With Acute Heart Failure
and Volume Overload.
J Am Coll Cardiol. 2023;81:2013-2024. PubMedAbstract available
JOYCE E Natriuretic Response as a Biomarker of Decongestion in ADHF: Beyond Going With
the Flow.
J Am Coll Cardiol. 2023;81:2025-2027. PubMed
KRISTENSEN SL, Jensen J, Schou M SGLT2 Inhibitors in Patients With Heart Failure and Chronic Kidney Disease:
Jigsaw Falling Into Place.
J Am Coll Cardiol. 2023;81:1915-1917. PubMed
BUTLER J, Packer M, Siddiqi TJ, Bohm M, et al Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney
Risk Categories.
J Am Coll Cardiol. 2023;81:1902-1914. PubMedAbstract available
INCIARDI RM, Abanda M, Shah A, Cikes M, et al Right Ventricular Function and Coupling to Pulmonary Circulation in Heart Failure
with Preserved Ejection Fraction: The PARAGON-HF Trial.
J Am Coll Cardiol. 2023 May 15:S0735-1097(23)05587. PubMedAbstract available
MENTZ RJ, Ward JH, Hernandez AF, Lepage S, et al Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved
Ejection Fraction and Worsening Heart Failure.
J Am Coll Cardiol. 2023 May 11:S0735-1097(23)05429. PubMedAbstract available
KITTLESON MM, Panjrath GS, Amancherla K, Davis LL, et al 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With
Preserved Ejection Fraction: A Report of the American College of Cardiology
Solution Set Oversight Committee.
J Am Coll Cardiol. 2023;81:1835-1878. PubMed
BORLAUG BA, Sharma K, Shah SJ, Ho JE, et al Heart Failure With Preserved Ejection Fraction: JACC Scientific Statement.
J Am Coll Cardiol. 2023;81:1810-1834. PubMedAbstract available
KODALI SK, Hahn RT, Davidson CJ, Narang A, et al 1-Year Outcomes of Transcatheter Tricuspid Valve Repair.
J Am Coll Cardiol. 2023;81:1766-1776. PubMedAbstract available
VENTURA HO, Lavie CJ, Mehra MR Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection
Fraction: You Win Some, You Lose Some.
J Am Coll Cardiol. 2023 May 3:S0735-1097(23)05526. PubMed
MAMIC P, Snyder M, Tang WHW Gut Microbiome-Based Management of Patients With Heart Failure: JACC Review Topic
of the Week.
J Am Coll Cardiol. 2023;81:1729-1739. PubMedAbstract available
FONAROW GC, Van Spall HGC, Januzzi JL Jr Team-Based Virtual Nudges to Overcome Clinician Inertia in Guideline-Directed
Medical Therapy for Heart Failure.
J Am Coll Cardiol. 2023;81:1694-1696. PubMed
April 2023
MIRANDA WR, Jain CC, Borlaug BA, Jaffe AS, et al Exercise Capacity, NT-proBNP, and Exercise Hemodynamics in Adults Post-Fontan.
J Am Coll Cardiol. 2023;81:1590-1600. PubMedAbstract available
LENA A, Wilkenshoff U, Hadzibegovic S, Porthun J, et al Clinical and Prognostic Relevance of Cardiac Wasting in Patients With Advanced
Cancer.
J Am Coll Cardiol. 2023;81:1569-1586. PubMedAbstract available
VERMA S, Bhatt DL, Dhingra NK, Steg PG, et al Time to Benefit With Sotagliflozin in Patients With Worsening Heart Failure.
J Am Coll Cardiol. 2023;81:1546-1549. PubMed
KHAN H, Kunutsor SK Nonsteroidal Anti-Inflammatory Drugs and Type 2 Diabetes: A Recipe for
Heart Failure?
J Am Coll Cardiol. 2023;81:1471-1473. PubMed
HOLT A, Strange JE, Nouhravesh N, Nielsen SK, et al Heart Failure Following Anti-Inflammatory Medications in Patients With Type 2
Diabetes Mellitus.
J Am Coll Cardiol. 2023;81:1459-1470. PubMedAbstract available
COCA SG Learning to Embrace the Decline in eGFR After Initiation of Therapies
for Heart Failure.
J Am Coll Cardiol. 2023;81:1456-1458. PubMed
AHMAD T, Desai NR, Clark KAA The EHR Has Exposed an Urgent Moral Imperative to Improve Heart Failure Care.
J Am Coll Cardiol. 2023;81:1317-1319. PubMed
YUN M, Bai Y, Nie B, Zhang X, et al Reply: Specific Brain-Heart Axis-Related Pathomechanism in Heart Failure Are
Revealed Through Analysis of Cardiovascular Dynamics.
J Am Coll Cardiol. 2023;81:e111. PubMed
VALENZA G Specific Brain-Heart Axis-Related Pathomechanism in Heart Failure Are Revealed
Through Analysis of Cardiovascular Dynamics.
J Am Coll Cardiol. 2023;81:e109. PubMed
CARNICELLI AP, Agarwal R, Tedford RJ, Ramaiah V, et al Critical Care Enrichment During Advanced Heart Failure Training.
J Am Coll Cardiol. 2023;81:1296-1299. PubMed
SORAJJA P, Cavalcante JL, Rodes-Cabau J Upstream Relief of Heart Failure Via Aortic Valve Replacement.
J Am Coll Cardiol. 2023;81:1245-1247. PubMed
KHAN KR, Khan OA, Chen C, Liu Y, et al Impact of Moderate Aortic Stenosis in Patients With Heart Failure With
Reduced Ejection Fraction.
J Am Coll Cardiol. 2023;81:1235-1244. PubMedAbstract available
March 2023
DOMANSKI MJ, Wu CO, Tian X, Hasan AA, et al Association of Incident Cardiovascular Disease With Time Course and Cumulative
Exposure to Multiple Risk Factors.
J Am Coll Cardiol. 2023;81:1151-1161. PubMedAbstract available
LYNCH A, Tatangelo M, Ahuja S, Steve Fan CP, et al Risk of Sudden Death in Patients With RASopathy Hypertrophic Cardiomyopathy.
J Am Coll Cardiol. 2023;81:1035-1045. PubMedAbstract available
DISMORR M, Glaser N, Franco-Cereceda A, Sartipy U, et al Effect of Prosthesis-Patient Mismatch on Long-Term Clinical Outcomes After
Bioprosthetic Aortic Valve Replacement.
J Am Coll Cardiol. 2023;81:964-975. PubMedAbstract available
VADUGANATHAN M, Claggett BL, Jhund P, Miao ZM, et al Dapagliflozin and All-Cause Hospitalizations in Patients With Heart Failure
With Preserved Ejection Fraction.
J Am Coll Cardiol. 2023;81:1004-1006. PubMed
SACHDEV V, Sharma K, Keteyian SJ, Alcain CF, et al Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection
Fraction: A Scientific Statement From the American Heart Association and American
College of Cardiology.
J Am Coll Cardiol. 2023 Mar 14:S0735-1097(23)00368. PubMedAbstract available
LAZARO I, Lupon J, Cediel G, Sala-Vila A, et al Reply: Circulating Vegetable Omega-3 and Prognosis in Patients With Heart
Failure: More Data Are Needed.
J Am Coll Cardiol. 2023;81:e69. PubMed
WU J, Liang J, Huang Y Circulating Vegetable Omega-3 and Prognosis in Patients With Heart Failure: More
Data Are Needed.
J Am Coll Cardiol. 2023;81:e67. PubMed
MENASCHE P Mesenchymal Stromal Cell Therapy for Heart Failure: Never Stop DREAMing.
J Am Coll Cardiol. 2023;81:864-866. PubMed
PERIN EC, Borow KM, Henry TD, Mendelsohn FO, et al Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy
in Patients With Heart Failure.
J Am Coll Cardiol. 2023;81:849-863. PubMedAbstract available
February 2023
BHATT AS, Varshney AS, Moscone A, Claggett BL, et al Virtual Care Team-Guided Therapeutic Optimization During Hospitalization in
Patients with Heart Failure: The IMPLEMENT-HF Study.
J Am Coll Cardiol. 2023 Feb 21:S0735-1097(23)04471. PubMedAbstract available
MUKHOPADHYAY A, Reynolds HR, Phillips LM, Nagler AR, et al Cluster-Randomized Trial Comparing Ambulatory Decision Support Tools to Improve
Heart Failure Care.
J Am Coll Cardiol. 2023 Feb 9:S0735-1097(23)00329. PubMedAbstract available